SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Orchid Pharma

BSE: 524372|NSE: ORCHIDPHAR|ISIN: INE191A01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 29, 16:01
41.50
0
VOLUME 89,009
LIVE
NSE
Apr 29, 16:01
41.55
0.05 (0.12%)
VOLUME 345,349
Announcements on Orchid Pharma

11th-Apr-2016 11:44Source: BSE

Orchid Pharma- Updates

Orchid Pharma Ltd has informed BSE that Orchid received the Establishment inspection report (EIR) from USFDA based on the successful inspection closure for the API manufacturing facility located at Al...

11th-Apr-2016 11:27Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange that the Company received the Establishment inspection report (EIR) from USFDA based on the successful inspection closure for the API manufacturing faci...

17th-Mar-2016 13:48Source: BSE

Orchid Pharma- Orchid receives final USFDA nod for Rasagiline generic formulation

Orchid Pharma Ltd has informed BSE regarding a Press Release dated March 17, 2016 titled "Orchid receives final USFDA nod for Rasagiline generic formulation".

17th-Mar-2016 13:23Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange regarding a press release dated March 17, 2016 titled "Orchid receives final USFDA nod for Rasagiline generic formulation".

10th-Feb-2016 10:48Source: BSE

Orchid Pharma- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

7th-Jan-2016 14:11Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange that Industrial Development Bank of India has withdrawn the nomination of Shri Nagaraj Garla and instead appointed Shri Rabinarayan Panda, Chief General...

7th-Jan-2016 13:37Source: BSE

Orchid Pharma- Change in Directorate

Orchid Pharma Ltd has informed BSE that Industrial Development Bank of India has withdrawn the nomination of Shri Nagaraj Garla and instead appointed Shri Rabinarayan Panda, Chief General Manager, IDB...

31st-Dec-2015 15:26Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange that the Company is pleased to announce that orchid received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection clo...

31st-Dec-2015 15:12Source: BSE

Orchid Pharma- Updates

Orchid Pharma Ltd has informed BSE that Orchid received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection closure for the formulation manufacturing facility locat...

22nd-Dec-2015 19:53Source: BSE

Orchid Pharma- Updates on Subsidiary Company

Orchid Pharma Ltd has informed BSE that Orchid Europe Limited, UK a wholly-owned subsidiary of Orchid Pharma Limited, India has entered into a long term financial arrangement to avail up to US$ 80...

1 2 3 4 5 Next >>
Quick Links for Orchid Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.